PharmaShots | Incisive News in 3 Shots

Subscribe Now

Von Hippel-Lindau Disease- Associated

Merck's MK-6482 Receives the US FDA's Breakthrough Therapy Designation to Treat Patients With Von Hippel-Lindau Disease-Associated Renal Cell Carcinoma

Merck's MK-6482 Receives the US FDA's Breakthrough Therapy Designation to Treat Patients With Von Hippel-Lindau Disease-Associated...

July 29, 2020

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us